Advocacy intelligence hub — real-time data for patient organizations
EMD Serono Research & Development Institute, Inc. — PHASE1
PepsiCo Global R&D — NA
Hospices Civils de Lyon
National Taiwan University Hospital — NA
Imagine Institute — NA
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
Epogen
Amgen, Inc.
Epogen
(Epoetin alfa)Orphan drugstandardAmgen, Inc.
12.1 Mechanism of Action Epogen stimulates erythropoiesis by the same mechanism as endogenous erythropoietin.
Browse all Autosomal dominant tubulointerstitial kidney disease news →
Kendrah O Kidd
Wake Forest University School of Medicine
Naoya Morisada
Kobe University Graduate School of Medicine
Martina Živná
Wake Forest University School of Medicine
Nana Sakakibara
Kobe University Graduate School of Medicine
Tomoko Horinouchi
Kobe University Graduate School of Medicine
Anthony J Bleyer, MD
Wake Forest University School of Medicine
📍 GREENVILLE, SC
View all Autosomal dominant tubulointerstitial kidney disease specialists →